Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection

• Published in: Terapevtic̆eskii arhiv Vol. 90; no. 8; pp. 33 - 39
• Main Authors: Yurenev, G L, Partzvania-Vinogradova, E V, Andreev, D N, Dicheva, D T, Maiev, I V
• Format: Journal Article
• Language: English; Russian
• Published: Russia (Federation) "Consilium Medicum" Publishing house 27.08.2018
• Subjects: Adult; Amoxicillin - administration & dosage; Amoxicillin - therapeutic use; Antacids - administration & dosage; Antacids - therapeutic use; Anti-Infective Agents - administration & dosage; Anti-Infective Agents - therapeutic use; Anti-Ulcer Agents - administration & dosage; Anti-Ulcer Agents - therapeutic use; Bismuth - administration & dosage; Bismuth - therapeutic use; Clarithromycin - administration & dosage; Clarithromycin - therapeutic use; Drug Administration Schedule; Drug Therapy, Combination; eradication therapy; Female; four-component therapy; Helicobacter Infections - complications; Helicobacter Infections - drug therapy; Helicobacter Infections - microbiology; helicobacter pylori; Helicobacter pylori - drug effects; Humans; hybrid therapy; Male; Metronidazole - administration & dosage; Metronidazole - therapeutic use; Omeprazole - administration & dosage; Omeprazole - therapeutic use; peptic ulcer; Peptic Ulcer - complications; Peptic Ulcer - drug therapy; Peptic Ulcer - microbiology; pharmacoeconomics; Prospective Studies; safety; Treatment Outcome; triple therapy; four-component therapy; Helicobacter pylori; triple therapy; eradication therapy; hybrid therapy; peptic ulcer; safety; pharmacoeconomics
• ISSN: 0040-3660; 2309-5342
• DOI: 10.26442/terarkh201890833-39

The aim is to conduct a comprehensive comparative study of the efficacy and safety of the hybrid scheme of eradication therapy (ET) in patients with peptic ulcer of the stomach or duodenum associated with Helicobacter pylori. Materials and methods. In a prospective, randomized comparative study, 180 patients were divided into three equal groups of 60 people, depending on the prescribed 10-day ET regimen. Group 1 - the standard triple scheme (omeprazole, amoxicillin and clarithromycin); group 2 - four-component therapy with preparations of bismuth (omeprazole, tetracycline, metronidazole, bismuth tricalium dicitrate); group 3 - hybrid scheme (first 5 days: omeprazole and amoxicillin, the next 5 days: omeprazole, amoxicillin, clarithromycin, metronidazole). The effectiveness of ET was determined with the help of a breath test a month after the end of therapy. Adverse events were recorded by patients in specially developed diaries. Pharmacoeconomic analysis was carried out using the "cost-effectiveness" method with calculation of the CER coefficient. Results and discussion. The effectiveness of standard triple therapy was 73.3% (ITT), 75.9% (PP); four-component therapy with bismuth preparations - 78.3% (ITT), 82.4% (PP); hybrid scheme - 85% (ITT), 91% (PP). Hybrid therapy proved to be significantly more effective than standard triple therapy with a odds ratio (OR) of 3.25; 95% confidence interval (CI) 1.08-9.73 (p=0.043, χ2=4.75, p-level=0.029298). The incidence of adverse events with the use of triple, four-component and hybrid ET regimens was 15; 18.3 and 28.3% respectively. The OR of at least one adverse event in patients receiving a hybrid ET regimen compared with triple therapy was 2.24 (95% CI 0.91-5.53, p=0.0823, χ2=3.14, p-level=0.076394), and compared with the four-component therapy - 1.76 (95% CI 0.74-4.17, p=0.2804, χ2=1.68, p-level=0.194924). According to the results of the pharmacoeconomic analysis, the most profitable from an economic point of view was a hybrid ET scheme with a CER of 20.1. The conclusion. Hybrid therapy showed the greatest effectiveness in comparison with the triple and four-component ET regimens, however, the incidence of side effects in patients receiving the hybrid ET scheme was higher, although it remained within the acceptable level for use in clinical practice. Pharmacoeconomic analysis also showed the advisability of designating a hybrid ET scheme. The obtained data allow to draw a conclusion about the necessity of further study of the efficiency and safety of the hybrid ET scheme.